IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-45848-1.html
   My bibliography  Save this article

Cyclic peptides discriminate BCL-2 and its clinical mutants from BCL-XL by engaging a single-residue discrepancy

Author

Listed:
  • Fengwei Li

    (Shandong University)

  • Junjie Liu

    (Xiamen University)

  • Chao Liu

    (Shandong University)

  • Ziyan Liu

    (Xiamen University)

  • Xiangda Peng

    (Shanghai Zelixir Biotech Company Ltd.)

  • Yinyue Huang

    (Shandong University)

  • Xiaoyu Chen

    (Shandong University)

  • Xiangnan Sun

    (Shandong University)

  • Sen Wang

    (Shandong University)

  • Wei Chen

    (Shanghai Jiao Tong University School of Medicine-Affiliated Renji Hospital)

  • Dan Xiong

    (Xiamen Lifeint Technology Company Ltd.)

  • Xiaotong Diao

    (Shandong University)

  • Sheng Wang

    (Shanghai Zelixir Biotech Company Ltd.)

  • Jingjing Zhuang

    (Shandong University
    Shandong University)

  • Chuanliu Wu

    (Xiamen University)

  • Dalei Wu

    (Shandong University)

Abstract

Overexpressed pro-survival B-cell lymphoma-2 (BCL-2) family proteins BCL-2 and BCL-XL can render tumor cells malignant. Leukemia drug venetoclax is currently the only approved selective BCL-2 inhibitor. However, its application has led to an emergence of resistant mutations, calling for drugs with an innovative mechanism of action. Herein we present cyclic peptides (CPs) with nanomolar-level binding affinities to BCL-2 or BCL-XL, and further reveal the structural and functional mechanisms of how these CPs target two proteins in a fashion that is remarkably different from traditional small-molecule inhibitors. In addition, these CPs can bind to the venetoclax-resistant clinical BCL-2 mutants with similar affinities as to the wild-type protein. Furthermore, we identify a single-residue discrepancy between BCL-2 D111 and BCL-XL A104 as a molecular “switch” that can differently engage CPs. Our study suggests that CPs may inhibit BCL-2 or BCL-XL by delicately modulating protein-protein interactions, potentially benefiting the development of next-generation therapeutics.

Suggested Citation

  • Fengwei Li & Junjie Liu & Chao Liu & Ziyan Liu & Xiangda Peng & Yinyue Huang & Xiaoyu Chen & Xiangnan Sun & Sen Wang & Wei Chen & Dan Xiong & Xiaotong Diao & Sheng Wang & Jingjing Zhuang & Chuanliu Wu, 2024. "Cyclic peptides discriminate BCL-2 and its clinical mutants from BCL-XL by engaging a single-residue discrepancy," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45848-1
    DOI: 10.1038/s41467-024-45848-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-45848-1
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-45848-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Richard W. Birkinshaw & Jia-nan Gong & Cindy S. Luo & Daisy Lio & Christine A. White & Mary Ann Anderson & Piers Blombery & Guillaume Lessene & Ian J. Majewski & Rachel Thijssen & Andrew W. Roberts & , 2019. "Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations," Nature Communications, Nature, vol. 10(1), pages 1-10, December.
    2. Peter Eastman & Jason Swails & John D Chodera & Robert T McGibbon & Yutong Zhao & Kyle A Beauchamp & Lee-Ping Wang & Andrew C Simmonett & Matthew P Harrigan & Chaya D Stern & Rafal P Wiewiora & Bernar, 2017. "OpenMM 7: Rapid development of high performance algorithms for molecular dynamics," PLOS Computational Biology, Public Library of Science, vol. 13(7), pages 1-17, July.
    3. Tilman Oltersdorf & Steven W. Elmore & Alexander R. Shoemaker & Robert C. Armstrong & David J. Augeri & Barbara A. Belli & Milan Bruncko & Thomas L. Deckwerth & Jurgen Dinges & Philip J. Hajduk & Mary, 2005. "An inhibitor of Bcl-2 family proteins induces regression of solid tumours," Nature, Nature, vol. 435(7042), pages 677-681, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Hudie Wei & Haolan Wang & Genxin Wang & Lingzhi Qu & Longying Jiang & Shuyan Dai & Xiaojuan Chen & Ye Zhang & Zhuchu Chen & Youjun Li & Ming Guo & Yongheng Chen, 2023. "Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    2. Birte Hernandez Alvarez & Julia Skokowa & Murray Coles & Perihan Mir & Masoud Nasri & Kateryna Maksymenko & Laura Weidmann & Katherine W Rogers & Karl Welte & Andrei N Lupas & Patrick Müller & Mohamma, 2020. "Design of novel granulopoietic proteins by topological rescaffolding," PLOS Biology, Public Library of Science, vol. 18(12), pages 1-26, December.
    3. Qiwen Su-Tobon & Jiayi Fan & Michael Goldstein & Kevin Feeney & Hongyuan Ren & Patrick Autissier & Peiyi Wang & Yingzi Huang & Udayan Mohanty & Jia Niu, 2025. "CRISPR-Hybrid: A CRISPR-Mediated Intracellular Directed Evolution Platform for RNA Aptamers," Nature Communications, Nature, vol. 16(1), pages 1-13, December.
    4. Christian Hentrich & Mateusz Putyrski & Hanh Hanuschka & Waldemar Preis & Sarah-Jane Kellmann & Melissa Wich & Manuel Cavada & Sarah Hanselka & Victor S. Lelyveld & Francisco Ylera, 2024. "Engineered reversible inhibition of SpyCatcher reactivity enables rapid generation of bispecific antibodies," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    5. Andreas Mardt & Tim Hempel & Cecilia Clementi & Frank Noé, 2022. "Deep learning to decompose macromolecules into independent Markovian domains," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    6. Cheng Shen & Yuqing Zhang & Wenwen Cui & Yimeng Zhao & Danqi Sheng & Xinyu Teng & Miaoqing Shao & Muneyoshi Ichikawa & Jin Wang & Motoyuki Hattori, 2023. "Structural insights into the allosteric inhibition of P2X4 receptors," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    7. Andrea Lopez & Denis E. Reyna & Nadege Gitego & Felix Kopp & Hua Zhou & Miguel A. Miranda-Roman & Lars Ulrik Nordstrøm & Swathi-Rao Narayanagari & Ping Chi & Eduardo Vilar & Aristotelis Tsirigos & Evr, 2022. "Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    8. John G Albeck & John M Burke & Sabrina L Spencer & Douglas A Lauffenburger & Peter K Sorger, 2008. "Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death," PLOS Biology, Public Library of Science, vol. 6(12), pages 1-1, December.
    9. F. P. Panei & P. Gkeka & M. Bonomi, 2024. "Identifying small-molecules binding sites in RNA conformational ensembles with SHAMAN," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    10. Bin Han & Kuang Yu, 2025. "Refining potential energy surface through dynamical properties via differentiable molecular simulation," Nature Communications, Nature, vol. 16(1), pages 1-12, December.
    11. Shana Bergman & Rosemary J. Cater & Ambrose Plante & Filippo Mancia & George Khelashvili, 2023. "Substrate binding-induced conformational transitions in the omega-3 fatty acid transporter MFSD2A," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    12. Kuang-Ting Ko & Frank Lennartz & David Mekhaiel & Bora Guloglu & Arianna Marini & Danielle J. Deuker & Carole A. Long & Matthijs M. Jore & Kazutoyo Miura & Sumi Biswas & Matthew K. Higgins, 2022. "Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    13. Hongjun Bai & Eric Lewitus & Yifan Li & Paul V. Thomas & Michelle Zemil & Mélanie Merbah & Caroline E. Peterson & Thujitha Thuraisamy & Phyllis A. Rees & Agnes Hajduczki & Vincent Dussupt & Bonnie Sli, 2024. "Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    14. Do Hoon Kwon & Feng Zhang & Brett A. McCray & Shasha Feng & Meha Kumar & Jeremy M. Sullivan & Wonpil Im & Charlotte J. Sumner & Seok-Yong Lee, 2023. "TRPV4-Rho GTPase complex structures reveal mechanisms of gating and disease," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    15. Xiaotong Diao & Qinghong Shang & Mengqi Guo & Yubin Huang & Meina Zhang & Xiaoyu Chen & Yinping Liang & Xiangnan Sun & Fan Zhou & Jingjing Zhuang & Shuang-Jiang Liu & Christoph F. A. Vogel & Fraydoon , 2025. "Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex," Nature Communications, Nature, vol. 16(1), pages 1-14, December.
    16. Ritaban Halder & Daniel A. Nissley & Ian Sitarik & Yang Jiang & Yiyun Rao & Quyen V. Vu & Mai Suan Li & Justin Pritchard & Edward P. O’Brien, 2023. "How soluble misfolded proteins bypass chaperones at the molecular level," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    17. Giacomo Janson & Gilberto Valdes-Garcia & Lim Heo & Michael Feig, 2023. "Direct generation of protein conformational ensembles via machine learning," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    18. Jeffrey A. Ruffolo & Lee-Shin Chu & Sai Pooja Mahajan & Jeffrey J. Gray, 2023. "Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    19. Jin H. Yang & Hugo B. Brandão & Anders S. Hansen, 2023. "DNA double-strand break end synapsis by DNA loop extrusion," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    20. Rodrigo G. Fernandez Lahore & Niccolò P. Pampaloni & Enrico Schiewer & M.-Marcel Heim & Linda Tillert & Johannes Vierock & Johannes Oppermann & Jakob Walther & Dietmar Schmitz & David Owald & Andrew J, 2022. "Calcium-permeable channelrhodopsins for the photocontrol of calcium signalling," Nature Communications, Nature, vol. 13(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45848-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.